Vir Biotechnology (VIR) Non Operating Income (2018 - 2026)
Vir Biotechnology (VIR) reported Non Operating Income of $6.79 million for Q2 2026, down 11.0% from $7.63 million a year earlier but up 0.4% from the prior quarter.
Vir Biotechnology (VIR) Non Operating Income (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vir Biotechnology's Non Operating Income came in at $28.89 million, down 48.8% year-over-year; for FY2025, it was $41.56 million, down 35.1% from FY2024.
- By year, Non Operating Income came in at $64.06 million in FY2024 (+14.2%), $56.11 million in FY2023, -$78.79 million in FY2022 and $129.05 million in FY2021.
- Five-year quarterly Non Operating Income spans a low of -$91.92 million in Q1 2022 and a high of $164.15 million in Q3 2021.
- Year over year, Non Operating Income has now declined in each of the last five quarters, with an average decline of 32.0% over the last eight quarters.
- The high point for year-over-year Non Operating Income in five years was Q1 2025 (growth of 23.3%); the low point was Q3 2022 (a decline of 86.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.77 million (Q1 2026), $4.86 million (Q4 2025) and $10.47 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Vir Biotechnology | 1.89 Bn | 1.89 Bn | 238.95 Mn | 6.79 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.79 Mn |
| Mar 31, 2026 | 6.77 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Sep 30, 2025 | 10.47 Mn |
| Jun 30, 2025 | 7.63 Mn |
| Mar 31, 2025 | 18.60 Mn |
| Dec 31, 2024 | 12.48 Mn |
| Sep 30, 2024 | 17.76 Mn |
| Jun 30, 2024 | 18.74 Mn |
| Mar 31, 2024 | 15.08 Mn |
| Dec 31, 2023 | 18.26 Mn |
| Sep 30, 2023 | 20.11 Mn |
| Jun 30, 2023 | 17.56 Mn |
| Mar 31, 2023 | 183,000.00 |
| Dec 31, 2022 | -1.14 Mn |
| Sep 30, 2022 | 22.77 Mn |
| Jun 30, 2022 | -8.50 Mn |
| Mar 31, 2022 | -91.92 Mn |
| Dec 31, 2021 | -25.86 Mn |
| Sep 30, 2021 | 164.15 Mn |
Vir Biotechnology Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=VIR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();